I was asked why the healthcare system refuses to take clinical hypnotherapy and mind-based therapies seriously becomes glaringly obvious when you look at the corporate blueprint of who the NHS do actually supports business-wise. The resistance isn’t clinical, it’s structural. The NHS, as it operates today, is no longer a self-contained public service. It has been fragmented into a transactional marketplace optimisedto feed a multi-billion-pound corporate pipeline. And a therapy that is affordable, deeply humane, and aims to make the patient entirely independent of that pipeline isn't just ignored, it is actively resisted. The Transactional Body: Why the System Resists True Healing When you ask why the medical establishment refuses to take hypnotherapy seriously, the standard answer is always a predictable, bureaucratic shield: "We require more large-scale, double-blind clinical trials." But this is a smoke screen. The real reason the system resists hypnotherapy is far more cynical: Hypnotherapy cannot be patented, bulk-manufactured, or packaged into a recurring corporate subscription. In this marketplace, a cured patient is a lost customer. A self-sufficient patient who can regulate their own nervous system, manage chronic pain, or overcome trauma without chemical intervention is an economic dead end. The system has become a giant funnel. It takes the goodwill, the desperation, and the tax money of the public, and uses it to feed an industrial corporate machine that doesn't have human benefit at its heart. To understand why a root-cause, mind-based therapy is kept on the margins, you only have to look at the actual histories, legal "sins," and ethical profiles of the top ten organisations and sectors that tap into the multi-billion-pound NHS procurement fund. The Corporate Blueprint: The Top 10 NHS Strategic Business Partners 1. Palantir Technologies (Tech & Data) Named after the evil all seeing eye in Lord of the Rings.... * **Who they are:** A data analytics giant co-founded by billionaire Peter Thiel and heavily backed early on by In-Q-Tel, the venture capital arm of the CIA.

There is a specific kind of vertigo that comes with being a patient in modern Britain. It’s the feeling of holding two entirely conflicting truths in your hands at once: the profound, tear-inducing gratitude for a surgeon who just saved your eyesight from slipping into darkness, and the burning, justifiable rage that you only needed that surgery because the system failed you for years. Recently, I lay on an NHS operating table for eye surgery. The technical skill was undeniable, the surgical techniques nothing short of amazing. The team stepped in at the precipice and stopped my vision from deteriorating further. For that specific, clinical moment of rescue, I am intensely grateful. But the brutal reality is that I should never have been on that table. For a long time, I suffered through the grueling side effects of medication that wasn’t working. I shouted loudly into the void of the health service, explaining that something was wrong, that my body was rejecting the treatment. Instead of being heard, I was met with a systemic shrug. I was made to feel like *I* was the problem as if my failing body was simply being difficult, rather than the medicine being wrong. Over the past two years, my encounters with the NHS have felt less like healthcare and more like a series of administrative errors. There have been incorrect diagnoses. There has been a endless pipeline of prescriptions. At one point, I engaged with the nutritional side of the service, laying out exactly what I eat, the daily habits, the deliberate choices I make to support my body. Their response? Change nothing. Do nothing different. No recommendations. No curiosity. It felt as though real medicine had left the building. In its place was a passive, automated script-writing service. In the ten years I have lived in England, I have experienced exactly *one* genuine, hands-on medical examination. The rest of the time? I talk, they look at a screen, and they prescribe. We recently changed our GP surgery, and I am incredibly relieved to report that this new practice actually conducts real medical examinations. They look, they touch, they investigate. But the fact that finding a doctor who actually examines a patient feels like winning a lottery is proof of how broken the baseline has become.

There is something deeply fascinating about nutritional science: the same compound that helps one part of the body heal can sometimes create challenges somewhere else entirely. And nicotinamide — also known as niacinamide, a form of vitamin B3 — is a perfect example of this complexity. At first glance, nicotinamide sounds almost universally beneficial. It is praised for its antioxidant properties, its role in cellular repair, its anti-inflammatory effects, and its ability to support energy production inside the mitochondria — the “power plants” of our cells. But once you begin looking at conditions like gout, histamine disorders, GLP-1 medications, hidradenitis suppurativa (HS), or glaucoma, the conversation becomes far more nuanced. Because biology is rarely simple. So… What Actually Is Nicotinamide? Nicotinamide (niacinamide) is one of the two primary supplemental forms of vitamin B3. The two main forms are: Nicotinamide / Niacinamide The non-flushing form commonly used in skincare, supplements, and research. Niacin (nicotinic acid) The flushing form that often causes redness, warmth, and tingling sensations. Both are forms of vitamin B3, but they behave differently in the body. Nicotinamide is particularly important because it helps the body create a coenzyme called NAD+ (nicotinamide adenine dinucleotide), which is essential for cellular energy production, DNA repair, mitochondrial function, and healthy ageing processes. Without enough NAD+, cells struggle to function efficiently. Why Nicotinamide Is Often Considered Anti-Inflammatory In most contexts, nicotinamide is actually considered protective and calming to inflammatory processes. Research has shown it may help: Reduce oxidative stress Lower inflammatory cytokines Support skin barrier repair Calm acne and rosacea Improve eczema Support cellular resilience This is why it appears in so many skincare products and inflammatory skin protocols. But here is the important part: Anti-inflammatory in one tissue does not automatically mean universally beneficial everywhere in the body.

Trading drops for a permanent solution. Today was a day of absolute validation at the RVI. If you had told me back on the 14th of March, when I was being offered steroids and invasive surgery for a flare-up—that I’d be standing here today with a "clean" eye, I’m not sure I would have believed it. But the work I’ve put in over the last six weeks has changed the game. Challenging the Textbooks When the consultant leaned into the slit-lamp today, the room went quiet. He couldn't find a single trace of the uveitis. No debris, no inflammatory cells, nothing. It was so pristine that he actually turned to his colleague and asked if there had ever been a recorded case of a "full recovery" from Fuchs. They eventually settled on the word "dormant," but I know better. The intensive systemic healing and the peptide protocols I’ve been running have been miraculously effective. To go from a surgical crisis in March to an eye so clear the doctors are questioning their own records is a win I’m going to savour. The New Roadmap: The PreserFlo MicroShunt Because my eye is now so "quiet," I am in the perfect position for the PreserFlo MicroShunt. Since I can't tolerate the systemic side effects of beta-blockers, the "fog" and the breathing issues, this tiny 8mm tube will handle the drainage for me. But here’s the catch: for this surgery to work, I have to stop healing. If my body repairs the surgery site as effectively as it just cleared the uveitis, the shunt will scar over and fail. I have to shift from "Building" to "Guarding." The Protocol Shift: Construction Holiday vs. Peacekeepers To give this shunt a chance to settle, I’m putting the "Construction Crew" on a strict holiday. I’m pausing the heavy-hitters: BPC-157, TB-500, ARA-290, and Semax. They did their job perfectly, but now I need my body to stay "lazy" so it doesn't knit that new drain shut. Instead, I’m moving to a "Quiet Eye" stack focused on CNS calm and pure inflammation control: 1. The Peacekeeper Peptides KPV: To keep the cellular inflammatory switches in my eye turned firmly to "OFF."

There’s a phrase often used in ophthalmology when dealing with chronic inflammatory eye disease: “It’s a balancing act.” And honestly, that’s exactly what it feels like. For years, my treatment journey has involved trying to preserve the structure of my eye while also managing the consequences of the very treatments designed to save it. It’s a constant negotiation between inflammation, pressure, pain, vision, medication tolerance, and surgical intervention. Clinically, I now sit at what would be described as Stage 4 of the uveitic glaucoma pathway, surgical intervention. But this is where I’ve decided to pause. Not because I’m “giving up.”Not because I’m ignoring medicine.But because I no longer believe the current pathway has fully considered the whole person. The Standard Journey The traditional progression often looks something like this: Stage 1: Inflammatory Control High-dose steroids and dilating drops are used to stop the immune system attacking the eye. Stage 2: Pressure Management As steroid use increases eye pressure, glaucoma medications are introduced to try and protect the optic nerve. Stage 3: Steroid-Sparing Therapy Systemic immune-modulating drugs and biologics are introduced to reduce dependency on steroids. Stage 4: Surgical Intervention When pressure remains uncontrolled, drainage surgeries or tube shunts are often recommended. And this is the point I’ve reached. Why I’m Pressing Pause What I’ve realised is that throughout this entire journey, almost every intervention has focused on the mechanics of the eye. Pressure.Drainage.Inflammation.Structural preservation. But very little attention has been paid to: - chronic stress, - nervous system dysregulation, - trauma, - sleep, - inflammation as a whole-body process, - nutrition, - movement, - metabolic health, - emotional wellbeing, - neuroplasticity, - or the role the mind may play in healing and adaptation. No one has truly sat down and explored the wider terrain of what might be contributing to ongoing inflammation and immune dysregulation.